Concepedia

Publication | Open Access

Phase II Trial of Loubo<sup>®</sup>(Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes

62

Citations

27

References

2013

Year

Abstract

The regimen of lobaplatin and pemetrexed is modestly active in metastatic breast cancer patients who failed anthracycline or taxanes, and the toxicity profile suggesting that the doses of chemotherapy should be further modified.

References

YearCitations

1976

1.3K

2005

950

2012

74

2012

63

2011

59

2011

59

1993

55

2012

54

2011

51

2012

51

Page 1